as of 10-28-2026 3:36pm EST
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | ALISO VIEJO |
| Market Cap: | 9.7B | IPO Year: | 2015 |
| Target Price: | $199.31 | AVG Volume (30 days): | 926.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.65 | EPS Growth: | -18.41 |
| 52 Week Low/High: | $80.91 - $191.62 | Next Earning Date: | 10-28-2026 |
| Revenue: | $507,442,000 | Revenue Growth: | 32.33% |
| Revenue Growth (this year): | 36.3% | Revenue Growth (next year): | 23.25% |
| P/E Ratio: | -279.95 | Index: | |
| Free Cash Flow: | -22455000.0 | FCF Growth: | N/A |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
CHIEF DEVELOPMENT OFFICER
Avg Cost/Share
$164.77
Shares
1,527
Total Value
$251,120.10
Owned After
69,603
CHIEF DEVELOPMENT OFFICER
Avg Cost/Share
$153.38
Shares
1,615
Total Value
$249,158.46
Owned After
69,603
CHIEF DEVELOPMENT OFFICER
Avg Cost/Share
$181.31
Shares
13,744
Total Value
$2,483,104.04
Owned After
69,603
Director
Avg Cost/Share
$190.00
Shares
2,500
Total Value
$475,000.00
Owned After
37,406
SEC Form 4
PRESIDENT & COO
Avg Cost/Share
$179.69
Shares
60,000
Total Value
$10,784,659.20
Owned After
72,588
SVP & CHIEF FINANCIAL OFFICER
Avg Cost/Share
$180.13
Shares
20,000
Total Value
$3,602,600.00
Owned After
43,906
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Navratil Tomas | GKOS | CHIEF DEVELOPMENT OFFICER | Oct 5, 2026 | Sell | $164.77 | 1,527 | $251,120.10 | 69,603 | |
| Navratil Tomas | GKOS | CHIEF DEVELOPMENT OFFICER | Sep 25, 2026 | Sell | $153.38 | 1,615 | $249,158.46 | 69,603 | |
| Navratil Tomas | GKOS | CHIEF DEVELOPMENT OFFICER | Aug 28, 2026 | Sell | $181.31 | 13,744 | $2,483,104.04 | 69,603 | |
| Kliman Gilbert H | GKOS | Director | Aug 19, 2026 | Sell | $190.00 | 2,500 | $475,000.00 | 37,406 | |
| Gilliam Joseph E | GKOS | PRESIDENT & COO | Aug 11, 2026 | Sell | $179.69 | 60,000 | $10,784,659.20 | 72,588 | |
| Thurman Alex R. | GKOS | SVP & CHIEF FINANCIAL OFFICER | Aug 7, 2026 | Sell | $180.13 | 20,000 | $3,602,600.00 | 43,906 | |
| WEN LEANA | GKOS | Director | Jul 31, 2026 | Sell | $167.63 | 525 | $88,005.75 | 21,092 |
SEC 8-K filings with transcript text
Oct 28, 2026 · 100% conf.
1D
-6.39%
$169.23
5D
-7.06%
$168.01
20D
-5.71%
$170.44
2 gkos-ex99_1.htm
Exhibit 99.1
Contact:
Chris Lewis
Vice President, Investor Relations & Corporate Affairs
clewis@glaukos.com
Glaukos Announces Third Quarter 2026 Financial Results
Aliso Viejo, CA – October 28, 2026 – Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced financial results for the third quarter ended September 30, 2026. Key highlights include:
• Record net sales of $211.0 million in Q3 2026 increased 58% year-over-year on a reported and constant currency basis.
• U.S. Glaucoma record net sales of $118.6 million in Q3 2026 increased 47% year-over-year.
• Corneal Health record net sales of $59.0 million in Q3 2026 increased 154% year-over-year.
• Gross margin of approximately 85% and non-GAAP gross margin of approximately 88% in Q3 2026.
• Net income of $2.0 million and non-GAAP net income of $28.5 million in Q3 2026.
• Diluted earnings per share (EPS) of $0.03 and non-GAAP diluted EPS of $0.47 in Q3 2026.
• Cash and cash equivalents, short-term investments, and restricted cash of $339.8 million at the end of Q3 2026, an increase of $50.5 million compared to $289.3 million at the end of Q2 2026.
• Raised 2026 net sales guidance to $775 million to $785 million, compared to $680 million to $700 million previously.
• Introduced preliminary 2027 net sales guidance of $1 billion.
“Our record third quarter results reflect successful global execution across our key global commercial and development priorities, leaving us well positioned to sustain our strong growth momentum driven by two transformational growth drivers in iDose TR and Epioxa,” said Thomas Burns, Glaukos chairman and chief executive officer. “We continue to successfully advance our robust pipeline of novel, dropless platform technologies designed to meaningfully advance the standard of care and improve outcomes for patients suffering from chronic eye diseases.”
Third Quarter 2026 Financial Results
Net sales in the third quarter of 2026 of $211.0 million increased 58% on a reported and constant currency basis, compared to $133.5 million in the same period in 2025.
Gross margin for the third quarter of 2026 was approximately 85%, compared to approximately 78% in the same period in 2025. Non-GAAP gross margin for the third quarter of 2026 was approximately 88%, compared to approximately 84% in the same period in 2025.
Selling, general and administrative (SG&A) expenses for the third quarter of 2026 increased 58% to $130.9 million, compared to $83.0 million in the same period in 2025. Non-GAAP SG&A expenses for the third quarter of 2026 increased 32% to $109.7 million, compared to $83.2 million in the same period in 2025.
GAAP and non-GAAP research and development (R&D) expenses for the third quarter of 2026 increased 26% to $48.1 million, compared to $38.1 million in the same period in 2025.
1
Income from operations in the third quarter of 2026 was $0.8 million, compared to operating loss of $16.4 million in the third quarter of 2025. Non-GAAP income from operations in the third quarter of 2026 was $27.3 million, compared to non-GAAP operating loss of $9.3 million in the third quarter of 2025.
Net income in the third quarter of 2026 was $2.0 million, or $0.03 per diluted share, compared to net loss of $16.2 million, or ($0.28) per diluted share, in the third quarter of 2025. Non-GAAP net income in the third quarter of 2026 was $28.5 million, or $0.47 per diluted share, compared to non-GAAP net loss of $9.2 million, or ($0.16) per diluted share, in the third quarter of 2025.
The company ended the third quarter of 2026 with approximately $339.8 million in cash and cash equivalents, short-term investments, and restricted cash, and no debt.
2026 Revenue Guidance
The company expects 2026 net sales to be in the range of $775 million to $785 million based on the latest foreign currency exchange rates.
2027 Preliminary Revenue Guidance
The company expects preliminary 2027 net sales to be $1 billion based on the latest foreign currency exchange rates.
Webcast & Conference Call
The company will host a conference call and simultaneous webcast today at 1:30 p.m. PT (4:30 p.m. ET) to discuss the results and provide additional information about the company’s financial outlook. A link to the webcast is available on the company’s website at http://investors.glaukos.com. To participate in the conference call, please dial 833-461-5787 (U.S.) or 585-542-9983 (international) and enter Conference ID 517868366. A replay of the webcast will be archived on the company’s website following completion of the call.
Quarterly Summary Document
The company has posted a document on its Investor Relations website under the “Financials & Filings – Quarterly Results” section titled “Quarterly Summary.” This Quarterly Summary document is de
Jul 29, 2026 · 100% conf.
1D
-6.39%
$151.34
Act: +4.24%
5D
-7.06%
$150.25
20D
-5.71%
$152.42
SEC.gov | Request Rate Threshold Exceeded
U.S. Securities and Exchange Commission
You’ve Exceeded the SEC’s Traffic Limit
Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.
Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.
The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.
For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.
For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.
Reference ID: 0.ce06d217.1785421187.36cc874f
More Information
Internet Security Policy
By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.
Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).
To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.
If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.
Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.
Note: We do not offer technical support for developing or debugging scripted downloading processes.
Apr 29, 2026 · 100% conf.
1D
+4.39%
$122.10
Act: +22.84%
5D
+11.04%
$129.87
Act: +15.65%
20D
+12.62%
$131.72
Act: -8.93%
SEC.gov | Request Rate Threshold Exceeded
U.S. Securities and Exchange Commission
You’ve Exceeded the SEC’s Traffic Limit
Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.
Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.
The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.
For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.
For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.
Reference ID: 0.e618d017.1784726458.7fb68be
More Information
Internet Security Policy
By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.
Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).
To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.
If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.
Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.
Note: We do not offer technical support for developing or debugging scripted downloading processes.
See how GKOS stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "GKOS Glaukos Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.